Our site uses cookies to make navigation as functional as possible, including "third party" cookies and "profiling cookies" designed to tailor on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here. If you proceed browsing this website, you will be consenting to the use of all cookies.

A. Menarini Diagnostics
at a glance

With more than 650 employees and a network of 10 affiliates throughout Europe, A. Menarini Diagnostics is one of the major diagnostics companies in Europe.

Specialized in the two business areas of Self Testing and Laboratory, we currently provide approximately 500 million sensors for self testing per year and we have close to 10,000 laboratory instruments installed all over Europe

Discover Menarini Apps

GlucoLog Mobile



GlucoLog Lite



GlucoLog Kids & Teens Diabetes



Tako Dojo



The fields of IVD in which A. Menarini Diagnostics is currently present in Europe

The Laboratory division of A. Menarini Diagnostics is present all over Europe and operates in the following fields:

  • Analysis of haemoglobins
  • Urinalysis
  • Autoimmunity
  • Cell Pathology

Thanks to an in-depth knowledge of the needs of professionals and an extensive and efficient service network, we are considered a solid and reliable partner

A. Menarini Diagnostics is synonymous with quality

Since 1976, our mission has been to improve the quality of people's lives and achieve maximum customer satisfaction by providing services and products for diagnostics and preventive medicine

All our systems and products comply with strict rules and regulations, fully satisfying the requirements of standards and Menarini quality controls.

A. Menarini Diagnostics is a company certified by a third party (TÜV SÜD) according to the EN ISO 9001:2015 and EN ISO 13485:2016 standards.

 

Latest News

Monday, 5th October 2020 - Digital event
The new test from A. Menarini Diagnostics to detect the presence of antigens can not only determine in just 12 minutes whether a patient is positive f...
READ ALL NEWS »

Immagine5637183992105597104

Immagine6637183992330978327

The value of every minute.

GlucoMen® Day CGM is a Continuous Glucose Monitoring system with needle-free insertion and which provides a new glucose value every minute for 14 days.

The GlucoMen® Day CGM is a real-time subcutaneous Continuous Glucose Monitoring system. Thanks to the unique GlucoMen® Day CGM  Sensor technology the tiny sensor wire is inserted under the skin without a guide needle, with a reduced risk of insertion pain and bleeding.
The electrochemical enzymatic sensor measures the glucose level in the interstitial fluid for 14 days, and the data is stored in the Transmitter and sent via Bluetooth to the dedicated App, which displays a new glucose value every minute.

GlucoMen® Day CGM allowing a great reduction in environmental impact.

For more information visit us: 

http://www.glucomenday.com

https://www.menarinidiagnostics.com/en-us/Home/Diabetes-care-products/Glucomen-day-CGM/Features

Immagine3637183994319104830

Immagine7637183994912772619

A.MENARINI DIAGNOSTICS AND CURETIS ENTER INTO STRATEGIC PAN-EUROPEAN EXCLUSIVE PARTNERSHIP FOR THE DISTRIBUTION OF CURETIS' UNYVERO

 

Florence, Italy, March 26th 2019 

A.Menarini Diagnostics will be the exclusive distributor for Unyvero Platform and application cartridges in numerous European countries and will deploy its commercial team for the marketing of Unyvero Platform across Europe. By way of this pan-European distribution partnership, the Curetis Unyvero Platform and all CE -IVD marked Unyvero Application Cartridges for rapid detection of pathogens and antimicrobial resistance markers will be exclusively marketed and sold by A.Menarini Diagnostics through its various national country organizations. A.Menarini Diagnostics will dedicate its combined sales, customer service, marketing, scientific affairs and operations support team staff for the commercialization of Curetis’ Unyvero product line.

Per maggiori informazioni

 

 

DRC, connectivity by A. Menarini Diagnostics

 

DRC - Diabetes Remote Control - is the A. Menarini Diagnostics solution developed to make the best possible use of the blood glucose and ketone test results saved in the memory of the glucose meters. This system means that data saved on A. Menarini Diagnostics glucose meters can now be sent to a smartphone or tablet. This is made possible by the use of glucose meters fitted with NFC (Near Field Communication) and BLE (next-generation Bluetooth Low Energy) communication systems or by means of Menarini’s dedicated novel devices able to transmit data by BLE such as the GlucoLog BT Plus (for use with A. Menarini Diagnostics glucose meters only) and special apps (GlucoLog Lite and GlucoLog Mobile). These apps have been specifically developed for use by both patients and healthcare professionals. Compatible with both Android and Apple systems, they can be downloaded free from the appropriate app stores. The use of these apps allows an important exchange of useful data that can improve the quality of glycaemia control and, consequently, also the quality of therapy, with significant advantages in terms of a reduction in complications.

Learn more about

  1. Therapy & Wellness

    Therapy and
    Wellness

    Discover all the therapeutic areas where Menarini is present with products marketed in Italy.

    Enter »

  2. Diagnostics

    Diagnostics

    A. Menarini Diagnostics responds in a concrete, comprehensive and competent manner to diagnostic and preventive medicine investigations.

    Enter »

  3. Biotechnology

    Biotechnology

    Menarini Biotech represents Italian excellence in research in the field of biologic drugs. Cutting-edge technologies

    Enter »

MENARINI PILLS OF ART

Concession granted by Italian Ministry for Cultural Heritage and Activities Read more